ExplantLab is an innovative orthogenomic biotech company dedicated to providing healthcare professionals with cutting-edge tools to eliminate the failure of orthopaedic implants. With a focus on patient-centered care, ExplantLab offers a range of products and services for both professionals and patients. Their flagship product, Orthotype, is a revolutionary genetic test that predicts the risk of implant failure in specific patients.

This groundbreaking technology harnesses the link between genetics and engineering, allowing for personalized care and optimal implant selection. With state-of-the-art equipment and over 14 years of expertise in analyzing explanted joints, ExplantLab is the largest independent retrieval unit in Europe. ExplantLab's commitment to advancing orthopaedic care extends beyond genetic testing.

They also offer Explant Analysis, which evaluates implant performance and patient outcomes, leading to more informed decisions and improved long-term health for patients. By reducing the likelihood of chronic pain and revision surgery, ExplantLab is not only benefiting individual patients but also the healthcare system as a whole. Experience the evolution in orthopaedics with ExplantLab's groundbreaking technologies and patient-focused solutions